Cancer Research

CORD:USE Cord Blood Bank Announces The Addition Of Dr. John Wagner, A Pioneer In The Use Of Umbilical Cord Blood Stem Cells, To

ORLANDO, Florida, January 30 /PRNewswire/-- John Wagner, M.D., recognized as a leader in the field of cord blood stem cell transplantation, has joined the team at CORD:USE Cord Blood Bank. Dr. Wagner's extensive experience and knowledge in transplant ...

Article - Anna Ohlden - Jan 30 2008 - 4:30pm

Oncolytics Biotech Inc. Proceeds To Full Enrolment In U.S. Phase II Sarcoma Clinical Trial

CALGARY, Canada, January 31 /PRNewswire/-- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has met the initial criteria to proceed to full enrolment in its U.S. Phase II trial to evaluate the intravenous adm ...

Article - Anna Ohlden - Jan 31 2008 - 2:30am

Laureate Announces Manufacturing Agreement With ARIUS For Trop-2 Targeting Antibody

PRINCETON, New Jersey, January 31 /PRNewswire/--- Laureate to Manufacture ARIUS' Product Candidate Trop-2 Signal Transduction Antibody ...

Article - Anna Ohlden - Jan 31 2008 - 7:31am

BRCA1 Mutation Discovery Explains Why Women With It Have 85 Percent Risk Of Breast Cancer

A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer; researchers from the University of Michigan Comprehensive Cancer Center found that BRCA1 plays a role in regulating breast stem cel ...

Article - News Staff - Jan 31 2008 - 10:46am

Got The Gout, Ebenezer? Cut Back On Soda

Gout, or metabolic arthritis, was considered by Hippocrates “the disease of kings” because only wealthy people with rich diets got it. This was true until the early 20th century when cases went down because of improved knowledge about it. But in the last 4 ...

Article - News Staff - Jan 31 2008 - 11:44pm

Interview With Gary Taubes (part 5)

Continued from Part 4: I interviewed Gary Taubes by phone a few weeks ago, shortly after he gave a talk about the main ideas of his new book — Good Calories, Bad Calories — at UC Berkeley. The interview lasted about 2 hours. This is part 5. SETH: Well, I ...

Article - Seth Roberts - Feb 7 2008 - 10:52am

Oncolytics Biotech Inc. Announces Publication Of Research On Combination Reovirus And Radiation Therapy

CALGARY, Canada, February 4 /PRNewswire/-- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer Research, London, U.K. published the results of ...

Article - Anna Ohlden - Feb 4 2008 - 12:30am

Nucletron And The Cancer Centre Of Northern Ireland Report The First IMRT Treatment Within CHHiP Clinical Trial With Oncentra(R)

VEENENDAAL, The Netherlands, February 4 /PRNewswire/-- Nucletron BV and clinicians at The Cancer Centre, Northern Ireland, proudly report the first IMRT clinical treatment within the Conventional or Hypofractionated High-Dose Intensity Modulated Radiother ...

Article - Anna Ohlden - Feb 4 2008 - 4:30am

Naringenin In Citrus Fruit May Help Combat Hepatitis C Infection

A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection. A team of researchers from the Massachusetts General ...

Article - News Staff - Feb 5 2008 - 3:11am

4SC And AiCuris Begin Collaboration For The Discovery Of Anti-Infective Drug Candidates

PLANEGG-MARTINSRIED, Germany, February 5 /PRNewswire/-- The Martinsried drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) and the Wuppertal-based AiCuris GmbH & Co KG today announced that they have entered into a research ...

Article - Anna Ohlden - Feb 5 2008 - 3:31am